These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8196357)

  • 1. Molecular markers of melanocytic tumor progression.
    Weterman MA; van Muijen GN; Bloemers HP; Ruiter DJ
    Lab Invest; 1994 May; 70(5):593-608. PubMed ID: 8196357
    [No Abstract]   [Full Text] [Related]  

  • 2. Markers of melanocytic tumour progression.
    Ruiter DJ; van Muijen GN
    J Pathol; 1998 Dec; 186(4):340-2. PubMed ID: 10209480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenic role of growth factors in melanoma.
    Richmond A
    Semin Dermatol; 1991 Sep; 10(3):246-55. PubMed ID: 1931574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth control by tumor suppressors in malignant melanoma.
    Coleman A; Robertson G; Lugo TG
    Receptor; 1995; 5(1):9-19. PubMed ID: 7613487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.
    Seftor EA; Brown KM; Chin L; Kirschmann DA; Wheaton WW; Protopopov A; Feng B; Balagurunathan Y; Trent JM; Nickoloff BJ; Seftor RE; Hendrix MJ
    Cancer Res; 2005 Nov; 65(22):10164-9. PubMed ID: 16288000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular correlates in the progression of normal melanocytes to melanomas.
    Halaban R
    Semin Cancer Biol; 1993 Jun; 4(3):171-81. PubMed ID: 8318693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrins and other adhesion molecules involved in melanocytic tumor progression.
    Edward M
    Curr Opin Oncol; 1995 Mar; 7(2):185-91. PubMed ID: 7756384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic pathways to melanoma tumorigenesis.
    Hussein MR
    J Clin Pathol; 2004 Aug; 57(8):797-801. PubMed ID: 15280398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of melanoma precursor lesions.
    Wang Y; Rao U; Mascari R; Richards TJ; Panson AJ; Edington HD; Shipe-Spotloe JM; Donnelly SS; Kirkwood JM; Becker D
    Cell Growth Differ; 1996 Dec; 7(12):1733-40. PubMed ID: 8959342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in malignant melanoma.
    Kashani-Sabet M; Leong SP; Sagebiel R
    Surg Oncol Clin N Am; 1997 Jul; 6(3):599-623. PubMed ID: 9210357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rb/E2F: a two-edged sword in the melanocytic system.
    Halaban R
    Cancer Metastasis Rev; 2005 Jun; 24(2):339-56. PubMed ID: 15986142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions.
    Gambichler T; Grothe S; Rotterdam S; Altmeyer P; Kreuter A
    Am J Clin Pathol; 2009 Jun; 131(6):782-7. PubMed ID: 19461083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous melanoma susceptibility and progression genes.
    de Snoo FA; Hayward NK
    Cancer Lett; 2005 Dec; 230(2):153-86. PubMed ID: 16297704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic progression of metastatic melanoma.
    Rodolfo M; Daniotti M; Vallacchi V
    Cancer Lett; 2004 Oct; 214(2):133-47. PubMed ID: 15363539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular aspects of malignant melanoma. Role of protooncogenes and oncosuppressor genes.
    Kremen J; Stríbrná J; Pohlreich P; Hradecký P
    Sb Lek; 1994; 95(4):321-31. PubMed ID: 8867703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use and application of special techniques in assessing melanocytic tumours.
    Busam KJ
    Pathology; 2004 Oct; 36(5):462-9. PubMed ID: 15370117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic bases of cutaneous tumors].
    Basset-Séguin N; Dereure O; Guillot B
    Ann Dermatol Venereol; 1995; 122(4):217-25. PubMed ID: 8526416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor-associated and epithelial markers in gastrointestinal tumors].
    Knuth A; Klingel R; Moll R; Dippold W; Meyer zum Büschenfelde KH
    Verh Dtsch Ges Inn Med; 1991; 97():414-9. PubMed ID: 1725565
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudoglandular-type melanoma: a rare melanoma variant.
    Tarlow MM; Nemlick AS; Rothenberg J; Schwartz RA
    J Cutan Pathol; 2008 Jun; 35(6):588-90. PubMed ID: 18005169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.